PNPaulo Roberto Carvalho Do Nascimento

Paulo Roberto Carvalho Do Nascimento

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paulo Roberto Carvalho Do Nascimento has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identifying Optimal Wearable Devices for Monitoring Mobility in Hospitalized Older Adults: Feasibility, Acceptability, and Validity Study

    by Paulo Nascimento, Renata Kirkwood, Lauren E Griffith, Mylinh Duong, Cody Cooper, Yujiao Hao, Rong Zheng, Samir Raza, Marla Beauchamp

    Background: Hospitalized, frail older adults have an increased risk of developing hospital-acquired disability associated with hospital practices of restricted physical activity and immobilization. The use of activity tracking wearable devices may allow identification and prevention of mobility decline, reducing hospital-acquired disability. Objective: This study aimed to identify the optimal wearable device and wear location for monitoring mobility in older hospitalized patients. Specific objectives included (1) comparison of the feasibility and acceptability of ActiGraph wGT3X-BT (ActiGraph LLC), MOX1 (Maastricht Instruments), MetaMotionC (mBientLab), and Fitbit Versa (Google) for continuous mobility monitoring and (2) determination of the concurrent validity of the selected device for detecting body posture and step count. Methods: Participants were recruited for this observational study in the acute medical care unit of an academic hospital in Hamilton, Ontario, Canada. Eligible patients were aged 60 years and older, able to undertake the mobility protocol, and had an anticipated length of stay greater than 4 days. The study was divided into 2 experiments. Experiment 1 evaluated the feasibility of 4 wearable devices and validated the derived data for body posture and step count. Experiment 2 involved a mobility assessment session and a 24-hour monitoring and feasibility period with the selected device from experiment 1. Results: The ActiGraph wGT3X-BT emerged as the most feasible device, demonstrating superior usability, data acquisition, and management. The thigh-worn ActiGraph accurately detected sedentary behavior, while the ankle-worn device provided detailed information on step counts and body postures. Bland-Altman plots and intraclass correlation coefficients indicated that the ankle-worn ActiGraph showed excellent reliability for step counting, with minimal bias and narrow limits of agreement. Patients expressed a high willingness to wear a continuous mobility tracking device at the hospital and at home. Conclusions: Thigh- and ankle-worn ActiGraph are optimal for assessing and monitoring mobility in older hospitalized patients. Challenges such as discomfort and device removal observed during the 24-hour monitoring period highlight areas for future studies. Overall, our findings support the integration of wearable technology in hospital settings to enhance mobility monitoring and early intervention strategies. Further research is warranted to evaluate the long-term use of wearable data for predicting health outcomes post hospitalization and informing clinical decision-making to promote early mobility.


  • Effectiveness of interventions for non-specific low back pain in older adults. A systematic review and meta-analysis

    by Paulo R.C. Do Nascimento, Leonardo O.P. Costa, Amanda C. Araujo, Stéphane Poitras, Martin Bilodeau


  • Exclusion of Older Adults from Ongoing Clinical Trials on Low Back Pain: A Review of the WHO Trial Registry Database

    by Paulo Roberto Carvalho Do Nascimento, Manuela Loureiro Ferreira, Stéphane Poitras, Martin Bilodeau

    Background/Objectives: The burden of low back pain (LBP) is high, especially for older adults who experience a higher number of years living with a disability. However, this population is not being well represented in clinical trials (CTs). This study analyzed the International Clinical Trial Registry Platform (ICTRP) database from the World Health Organization to verify the future trend in the participation of older adults in registered CTs on LBP. Design: We performed a cross‐sectional review of the ICTRP searching for prospective protocols planning interventions for LBP with registration dates from January 2015 through November 2018. From the protocols of the eligible studies, we extracted those planning to include older adults. Results: A total of 167 protocols for CTs for LBP were planning to recruit participants older than 65 years. However, only five registries (2.99%; pooled sample = 169 participants) were designed to target participants specifically older than 65 years. The exclusion of older participants was not justified and imposed through an arbitrary upper‐age limit in 93.6% of the protocols. Most of the protocols are from single‐center studies, and a greater number are planned to be carried out in developed regions. Higher interest was in pharmacologic interventions, devices/technology, and physical rehabilitation. Conclusion: Older adults with LBP will continue to be underinvestigated in CTs for LBP in the near future. In general, ongoing trials are small, planned in developed regions, and proposing pharmacologic interventions to deal with LBP. J Am Geriatr Soc 67:603–608, 2019.


  • Open Access

    How do we define and measure sarcopenia? Protocol for a systematic review

    by Paulo Roberto Carvalho Do Nascimento, Stéphane Poitras, Martin Bilodeau

    The loss of muscle mass is a natural aging consequence. A reduction of muscle mass that surpasses the physiological rate is considered the key factor responsible for the development of a geriatric syndrome called sarcopenia. However, a new understanding of the importance of muscle quality over quantity is rising; as a result, different definitions for sarcopenia has been used. Due to the negative impact on elder’s health and quality of life, the number of research investigating the causes, prevalence, and management of sarcopenia is increasing, although a consensus on sarcopenia definition is still missing. This systematic review will assess observational studies reporting the presence of sarcopenia aiming to verify how sarcopenia is defined, the diagnosis criteria, and the tools used for assessment. In addition, we will investigate the influence of the definition and diagnostic tools on the prevalence rate. Keywords related to the condition, population, and type of study will be combined to build a search strategy for each of the following databases MEDLINE, EMBASE, CINAHL (Cumulative Index to Nursing and Allied Health Literature), Web of Science, and Google Scholar. Two independent reviewers will analyze the retrieved papers for eligibility and the methodological quality of eligible studies. The definition of sarcopenia and diagnostic tools used in each study and the prevalence estimates will be extracted. Descriptive statistics will be used to report the definitions of sarcopenia, diagnostic tools, and whether these influence or not, the prevalence rates. Sarcopenia is receiving greater attention in geriatrics research in recent years. Therefore, it is important to investigate how this condition is defined in the literature and whether these definitions can interfere with the reported estimates devoting more efforts on the topic. The results of this study can help to determine the most used definitions of sarcopenia reported in the literature, its strengths and limitations, and open a discussion about a need for a more valid, easy, and suitable one. PROSPERO CRD42015020832


  • Open Access

    Prevalência da dor lombar no Brasil: uma revisão sistemática

    by Paulo Roberto Carvalho Do Nascimento, Leonardo Oliveira Pena Costa

    O artigo descreve a qualidade metodológica dos estudos publicados sobre prevalência de dor lombar realizados no Brasil. Dezoito estudos foram considerados elegíveis após pesquisas nas seguintes bases de dados: LILACS, PubMed, Embase, CINAHL, SPORTDiscus e SciELO. Alto risco de viés foi encontrado nos critérios de validade externa relacionados com a amostragem, e viés de não-resposta. Considerando os critérios de validade interna, a principal fonte de viés estava relacionada com a falta de uma definição de caso aceitável, bem como a utilização de instrumentos que não apresentavam construto de confiabilidade e a validade provados. Nenhum estudo representativo com valores de prevalência da dor lombar no Brasil foi encontrado. Os trabalhos publicados incluídos nesta revisão apresentaram um alto risco de viés que afetam os dados de prevalência. Futuros estudos com desenho metodológico adequado são necessários, a fim de apresentar o real impacto da dor lombar no Brasil e permitir comparações.